• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 28-Nov-2022 EOD, Market Closed
SENSEX
62,504.80
211.16 (0.34%)
NIFTY
18,562.75
50.00 (0.27%)
    No Companies Visited

Back to news list
  • Sun Pharma chairman to retire on completion of term

    The drug major announced that its chairman and member of the board, Israel Makov, will retire from the company on 29 August 2022.

    Makov led the organisation for 10 years. He was appointed a board member and the chairman in 2012. Under his leadership, Sun Pharma transformed from a $1.7 billion organisation focusing on India and the US into the world's fourth largest specialty generic pharmaceutical company operating across 100+ markets with a turnover of over $5 billion. Leading the company's global expansion, he guided the acquisition of Ranbaxy in 2014, making Sun Pharma the leader in the Indian pharmaceutical market and a strong player globally. Makov helped steer the company to pursue its strategy of building a global pipeline of specialty products. Israel Makov said "I was fortunate to be part of the thrilling journey of Sun Pharma becoming a major global player in the pharmaceutical industry. I especially enjoyed working with the talented executives of Sun Pharma who participated in the company's transformation and successfully led the process of change. I am proud of what this incredible company has accomplished and am grateful to my colleagues and all the members of the Board for their trust and support." Sun Pharma managing director, Dilip Shanghvi said, "We thank Mr Makov for his visionary leadership and his contribution towards making Sun Pharma a global pharmaceutical company. I have always admired his business acumen and strategic orientation. Mr Makov has played a significant role in Sun Pharma's global expansion in the last decade. He guided the company into its next phase of growth with focus on innovation and adoption of newer technologies. The Board is sincerely grateful to Mr Makov for his dedication and wishes him all the best for the future."

    Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. Its global presence is supported by manufacturing facilities spread across six continents and approved by multiple regulatory agencies, coupled with a multi-cultural workforce comprising over 50 nationalities.

    Sun Pharmaceutical Industries' consolidated net profit surged 42.7% to Rs 2,060.88 crore on 10.08% increase in revenue from operations to Rs 10,643.97 crore in Q1 FY23 over Q1 FY22. The drug maker said that excluding covid products sales for Q1 last year, overall sales are up about 14%.

    Shares of Sun Pharma fell 0.20% to Rs 916.75 on Tuesday, 2 August 2022.



    Back to news list
Previous Stories :
More






Hot Pursuit News

Quick Links

Market Statistics

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 28-Nov-2022
  •  ( 17:55) Dharmaj Crop Guard IPO subscribed 1.79 times  
  •  ( 16:53) Benchmarks hit record high levels; Nifty ends at 18,562.75  
  •  ( 15:46) Indus Towers board OKs Rs 1,500-crore NCD issue  
  •  ( 14:34) Auto stocks in demand  
  •  ( 14:34) Shares pare some gains  
  •  ( 14:33) Indian Oil Corp issues NCDs worth Rs 2,500 cr  
  •  ( 12:38) Sensex, Nifty at record high; IT stocks advance  
  •  ( 12:05) L&T bags ‘significant' orders for hydrocarbon business  
  •  ( 11:37) HFCL bags order from SWSM for 1,770 crore  
  •  ( 11:34) Metal stocks tumble  
  •  ( 11:34) Benchmarks hit fresh intraday high  
  •  ( 11:04) Hero MotoCorp hikes ex-showroom prices from Dec 1  
  •  ( 10:39) LIC pares stake in Siemens, DCM  
  •  ( 10:29) Oil & Gas stocks rise for 5th day  
  •  ( 10:29) Barometers trade with strong gains  
  •  ( 09:59) Lemon Tree Hotels signs new property in Jamshedpur  
  •  ( 09:32) Strong market breadth  
  •  ( 09:31) Indices trade sideways amid volatility  
  •  ( 08:34) Asian stocks trading lower  
  •  ( 08:11) Max Financial to acquire residual stake in Max Life  
Show News
28 November 2022 00:00
3151.80
(1.44 %)
891.40
(0.42 %)
6779.15
(0.49 %)
1653.15
(1.22 %)
837.45
(-1.10 %)
4401.15
(-0.38 %)
2658.85
(-0.85 %)
1119.00
(-0.78 %)
1599.75
(-1.08 %)
2525.50
(-0.44 %)
936.45
(0.72 %)
1197.95
(0.83 %)
1623.25
(-0.46 %)
339.95
(-0.10 %)
1928.60
(0.01 %)
2064.10
(0.09 %)
1250.70
(-0.79 %)
9004.90
(-0.13 %)
19821.00
(1.50 %)
170.30
(0.29 %)
221.45
(0.41 %)
2708.05
(3.48 %)
608.70
(0.21 %)
1034.05
(0.07 %)
104.90
(-1.22 %)
3397.40
(0.25 %)
1077.35
(-0.24 %)
2590.85
(-0.18 %)
6891.70
(0.26 %)
405.70
(0.76 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.